Today, Ginkgo Bioworks, the organism company, announced a Series E financing round of $290 million with participation from all existing major investors and other new investors including funds and accounts advised by T. Rowe Price Associates, Inc., bringing the company's total funding to $719 million. The latest round of funding will be used to further expand the reach of … [Read more...] about Ginkgo Bioworks Raises $290 Million in Series E Financing to Grow its Platform for Cell Programming, accelerates widespread adoption of synthetic biology, including new partnerships with startup accelerators Y Combinator and Petri